We have located links that may give you full text access.
English Abstract
Journal Article
[The fate of corneal transplants from the Zurich eye bank].
In a retrospective study, we investigated the survival of transplanted corneal material, which had been sent between 1988 and 1989 from the Zurich Eye Bank to both domestic and foreign physicians and clinics. A questionnaire was used to determine diagnosis, transplant survival, cause of any opacification, the occurrence of problems of epithelialisation, loosening of sutures, as well as vascularization of the host cornea. Of a total of 416 corneas, 327 or 79% could be evaluated. The mean follow-up periods of the various diagnostic groups ranged from 11 to 20 months, with a range of 1 to 35 months. After 18 months, the rate of clear transplants was 96% in the keratokonus group. This rate was significantly better than that of the bullous keratopathy group (77%, p less than 0.013) or that of all other diagnosis groups (72%, p less than 0.001). The difference to the 81% survival rate of the group with Fuchs' endothelial dystrophy was not significant. The most frequent cause of transplant opacification was primary transplant failure. Analysis of possible risk factors further confirmed that transplant opacification occurs more frequent in the presence of vascularization of the host cornea.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app